Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

31 Mar 2025 15:14

RNS Number : 9789C
Persimmon PLC
31 March 2025
 

 

31 March 2025

Persimmon Plc (the "Company")

 

Director/PDMR Shareholding

 

Persimmon Plc announces that on 28 March 2025 awards were granted to Dean Finch, Group Chief Executive, and Andrew Duxbury, Chief Financial Officer, over 59,854 and 31,122 shares respectively, under the Persimmon Plc 2020 Deferred Bonus Plan. The awards are for the deferred element of the Executive Directors' annual bonus and will ordinarily vest after a three-year period ending on the announcement of the Group's 2027 results.

 

In the case of Andrew Duxbury, this includes the deferred element of his bonus for the buy-out period prior to his joining Persimmon. Further details are included in the Persimmon Directors' Remuneration Report for the year ended 31 December 2024.

 

The below notification, made in accordance with the requirements of the UK Market Abuse Regulation, gives further details:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Dean Finch

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Chief Executive

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2020 Deferred Bonus Plan for the deferred element of Dean Finch's 2025 annual bonus, which will ordinarily vest after a 3-year period ending on the announcement of the Group's 2027 results.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

59,854

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

28 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Andrew Duxbury

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2020 Deferred Bonus Plan for the deferred element of Andrew Duxbury's 2025 annual bonus, which will ordinarily vest after a 3-year period ending on the announcement of the Group's 2027 results.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

31,122

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

28 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

Tracy Davison

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALDFDFDSEFA
Date   Source Headline
8th Dec 20203:50 pmRNSDirector/PDMR Shareholding
1st Dec 20203:22 pmRNSBlock listing Interim Review
1st Dec 20203:01 pmRNSTotal Voting Rights
25th Nov 202011:50 amRNSAdditional Listing
10th Nov 20207:00 amRNSThird Quarter Trading Statement
2nd Nov 20203:11 pmRNSTotal Voting Rights
27th Oct 20203:37 pmRNSAdditional Listing
16th Oct 202012:46 pmRNSGrant of SAYE Option
29th Sep 202012:27 pmRNSDirector/PDMR Shareholding
8th Sep 202010:25 amRNSNew Chief Executive Officer Start Date
1st Sep 20202:00 pmRNSTotal Voting Rights
28th Aug 20202:02 pmRNSDirector/PDMR Shareholding
26th Aug 20207:44 amRNSPersimmon Plc (PSN) - Additional Listing
19th Aug 20207:02 amRNSUpdate on Chief Executive Officer Appointment
18th Aug 20207:00 amRNSHalf Year Results
20th Jul 20201:49 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSTrading Update
1st Jul 202012:42 pmRNSTotal Voting Rights
29th Jun 20204:58 pmRNSAppointment of CEO
24th Jun 20207:00 amRNSAppointment of new Chief Executive Officer
8th Jun 20204:17 pmRNSDirectorate Change
5th Jun 202010:00 amRNSDirector/PDMR Shareholding
1st Jun 20202:05 pmRNSBlock listing Interim Review
1st Jun 20201:13 pmRNSTotal Voting Rights
26th May 20202:28 pmRNSDirector/PDMR Shareholding
20th May 20208:40 amRNSDirector Declaration
14th May 20207:00 amRNSCOVID-19 Update
1st May 20201:56 pmRNSTotal Voting Rights
29th Apr 20203:34 pmRNSResult of AGM
29th Apr 20207:01 amRNSBoard Change
29th Apr 20207:00 amRNSTrading Update
27th Apr 20204:32 pmRNSDisclosure of rights attached to equity shares
24th Apr 20207:00 amRNSCOVID-19 Update
3rd Apr 20209:16 amRNSDirector Declaration
2nd Apr 20206:14 pmRNSFurther Update on Covid-19 – Board Remuneration
1st Apr 20209:51 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSCovid-19, Capital Return Plan and AGM Updates
17th Mar 20203:42 pmRNSAnnual Financial Report
16th Mar 20207:00 amRNSAppointment of Joint Corporate Broker
5th Mar 20204:47 pmRNSDirector/PDMR Shareholding
2nd Mar 202011:05 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSCEO Succession
27th Feb 20207:00 amRNSFinal Results
17th Feb 20207:00 amRNSBoard Change
3rd Feb 202012:00 pmRNSTotal Voting Rights
15th Jan 20207:02 amRNSBoard Change
15th Jan 20207:00 amRNSTrading Update
2nd Jan 202011:01 amRNSTotal Voting Rights
2nd Dec 201912:45 pmRNSBlock listing Interim Review
18th Nov 20193:48 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.